(PTI) Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at ₹1,247 crore in the third quarter ended December 31, 2022.
The drug firm had reported a net profit of ₹706 crore in the October-December period of the previous fiscal.
Revenue from operations rose to ₹6,770 crore during the period under review as against ₹5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.
What is EBITDA
First Published: 25 Jan 2023, 05:17 PM IST